Evidence map›Paper›PMID 32899054›Full record

ArticleMedicine2020

Tuberculosis infection in children visiting friends and relatives in countries with high incidence of tuberculosis: A study protocol.

Antoni Soriano-Arandes, Joan A Caylà, Alessandra Queiroga Gonçalves, Àngels Orcau, Antoni Noguera-Julian, Emma Padilla, Elisabet Solà-Segura, Neus Rius Gordillo, María Espiau, Mónica G García-Lerín and 9 more

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04236765 (Tuberculosis Infection in Children Visiting Friends and Relatives in Countries With High Incidence of Tuberculosis), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.0field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04236765 naunknown statusnot on this map

Tuberculosis Infection in Children Visiting Friends and Relatives in Countries With High Incidence of Tuberculosis: a Study Protocol

TypeinterventionalSponsorHospital Mutua de TerrassaRan2018 to 2020Enrolled492ConditionsTuberculosis InfectionArmsTB infection-screening benefiting group
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 2 countries.

Antoni Soriano-ArandesUnitat de Patologia Infecciosa i Immunodeficiències Pediàtriques, Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron.
Joan A CaylàFundació de la Unitat d'Investigació en Tuberculosi de Barcelona, Barcelona.
Alessandra Queiroga GonçalvesUnitat de Suport a la Recerca Terres de l'Ebre, Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol).
Àngels OrcauServei d'epidemiologia, Agència de Salut Pública de Barcelona, Barcelona.
Antoni Noguera-JulianCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid.
Emma PadillaÀrea de Microbiologia de Catlab, Terrassa.
Elisabet Solà-SeguraEquip d'Atenció Primària Vic Nord, Institut Català de la Salut, Vic.
Neus Rius GordilloServei de Pediatria Hospital Universitari Sant Joan de Reus, Reus.
María EspiauUnitat de Patologia Infecciosa i Immunodeficiències Pediàtriques, Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron.
Mónica G García-LerínAtenció Primària, Fundació Assistencial Mútua Terrassa, Terrassa.
Maria Àngels Rifà-PujolEquip d'Atenció Primària Tona, Institut Català de la Salut, Tona.
Jordi Gómez I PratEquip de Salut Pública i Comunitària de la Unitat de Salut Internacional Drassanes-Hospital Universitari Vall d'Hebron, Servei de Medicina Preventiva de Vall d'Hebron, Barcelona.
Esperança Macia-RieradevallEquip d'atenció primària Manlleu, Institut Català de la Salut, Manlleu.
Andrea Martin-NaldaUnitat de Patologia Infecciosa i Immunodeficiències Pediàtriques, Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron.
Maria Eril-RiusEquip d'atenció primària La Vall del Ges, Institut Català de la Salut, Torelló.
José Santos SantiagoCentre de Salut Internacional i Malalties Transmissibles Drassanes/Vall d'Hebron. Programa de Salut Internacional de l'ICS (PROSICS), Barcelona.
Lídia Busquets-PobletServei de pediatría, CAP El Remei, L'Equip d'Assistència Primària de Vic, Vic.
Raisa Morales MartínezCentre de Salut Internacional i Malalties Transmissibles Drassanes/Vall d'Hebron. Programa de Salut Internacional de l'ICS (PROSICS), Barcelona.
Tomàs Maria Pérez-PorcunaAtenció Primària, Fundació Assistencial Mútua Terrassa, Terrassa.
Institut Català de la Salut · ESVall d'Hebron Institut de Recerca · ESMútua Terrassa · ESCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESHospital Sant Joan de Déu Barcelona · ESHospital Universitari Sant Joan de Reus · ESVall d'Hebron Hospital Universitari · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTuberculosis (TB) is a global infectious disease. In low-incidence countries, paediatric TB affects mostly immigrant children and children of immigrants. We hypothesize that these children are at risk of exposure to Mycobacterium tuberculosis when they travel to the country of origin of their parents to visit friends and relatives (VFR). In this study, we aim to estimate the incidence rate and risk factors associated to latent tuberculosis infection (LTBI) and TB in VFR children. METHODS AND ANALYSIS: A prospective study will be carried out in collaboration with 21 primary health care centres (PCC) and 5 hospitals in Catalonia, Spain. The study participants are children under 15 years of age, either immigrant themselves or born to immigrant parents, who travel to countries with high incidence of TB (≥ 40 cases/100,000 inhabitants). A sample size of 492 children was calculated. Participants will be recruited before traveling, either during a visit to a travel clinic or to their PCC, where a questionnaire including sociodemographic, epidemiological and clinical data will be completed, and a tuberculin skin test (TST) will be performed and read after 48 to 72 hours; patients with a positive TST at baseline will be excluded. A visit will be scheduled eight to twelve-weeks after their return to perform a TST and a QuantiFERON-TB Gold Plus test. The incidence rate of LTBI will be estimated per individual/month and person/year per country visited, and also by age-group. ETHICS AND DISSEMINATION: The study protocol was approved by the Clinical Research Ethics Committee of the Hospital Universitari Mútua Terrassa (code 02/16) and the Clinical Research Ethics Committee of the Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (code P16/094). Articles will be published in indexed scientific journals.

trial registrationClinical-Trials.gov: NCT04236765.

Indexed as

Latent TuberculosisMycobacterium tuberculosisAdolescentChildClinical Trials as TopicDiagnostic Tests, RoutineEmigrants and ImmigrantsFamilyFemaleFriendsHumansIncidenceInterferon-gamma Release TestsMaleMulticenter Studies as TopicProspective Studies

Identifiers

PMID32899054
PMCPMC7478479
OpenAlexW3081840779

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.